Journal article

Beam characterisation studies of the 62 MeV proton therapy beamline at the Clatterbridge Cancer Centre

Jacinta Yap, Javier Resta-Lopez, Andrzej Kacperek, Roland Schnuerer, Simon Jolly, Stewart Boogert, Carsten Welsch

Physica Medica | ELSEVIER SCI LTD | Published : 2020


The Clatterbridge Cancer Centre (CCC) in the United Kingdom is the world’s first hospital proton beam therapy facility, providing treatment for ocular cancers since 1989. A 62 MeV beam of protons is produced by a Scanditronix cyclotron and transported through a passive delivery system. In addition to the long history of clinical use, the facility supports a wide programme of experimental work and as such, an accurate and reliable simulation model of the treatment beamline is highly valuable. However, as the facility has seen several changes to the accelerator and beamline over the years, a comprehensive study of the CCC beam dynamics is needed to firstly examine the beam optics. An extensive..

View full abstract

University of Melbourne Researchers


Awarded by European Union

Awarded by Horizon 2020 research and innovation programme: Marie Sklodowska-Curie grant

Awarded by Cockcroft Institute core grant

Funding Acknowledgements

We would like to express gratitude to our colleagues for many helpful discussions which supported this study. Thank you Tomasz Cybulski, Hao Zhang, Hywel Owen, Alexandra Alexandrova, Chris Edmonds, Volodymyr Rodin, Lina Hoummi & Ewa Oponowicz. The authors also appreciate the provision of beamline information and technical assistance from Brian Marsland, Ian Taylor and Oleg Karamyshev. This research was funded by the European Union FP7 grant agreement 215080, Horizon 2020 research and innovation programme: Marie Sklodowska-Curie grant agreement No. 675265 Optimization of Medical Accelerators (OMA) project and the Cockcroft Institute core grant STGA00076-01.